Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Plus Therapeutics (PSTV) has shared an update.
Plus Therapeutics, Inc. is set to experience a change in its executive team as Dr. Norman LaFrance, the Chief Medical Officer, has tendered his resignation, which will take effect on June 12, 2024.
Find detailed analytics on PSTV stock on TipRanks’ Stock Analysis page.